We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
(-8.6%)
Cap. Flow
-$915M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$161M |
| 2 |
Church & Dwight Co
CHD
|
+$150M |
| 3 |
Advanced Micro Devices
AMD
|
+$78.9M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$56.9M |
| 5 |
AstraZeneca
AZN
|
+$53.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$170M |
| 2 |
AT&T
T
|
+$142M |
| 3 |
Microsoft
MSFT
|
+$136M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$110M |
| 5 |
Amazon
AMZN
|
+$86.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.53% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Communication Services | 9.89% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Staples | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
2026
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $103K | ﹤0.01% |
543
+117
| +27% | +$27.1K |
|
2027
OneSpaWorld
OSW
$2.67B
| $102K | ﹤0.01% |
10,034
-1,653
| -14% | -$16.8K |
|
2028
Select Water Solutions
WTTR
$2.51B
| $102K | ﹤0.01% |
11,953
-1,699
| -12% | -$13.2K |
|
|
IDEX
2029
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $102K | ﹤0.01% |
730
-38
| -5% | -$4.85K |
|
|
AGEN
2030
Agenus
AGEN
$249M
| $101K | ﹤0.01% |
2,094
-346
| -14% | -$18.7K |
|
2031
Porch Group
PRCH
$1.3B
| $100K | ﹤0.01% |
14,305
-2,543
| -15% | -$23.5K |
|
|
DNMR
2032
DELISTED
Danimer Scientific, Inc.
DNMR
| $100K | ﹤0.01% |
425
-70
| -14% | -$14.1K |
|
|
MRNS
2033
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $100K | ﹤0.01% |
10,743
-2,502
| -19% | -$24.9K |
|
|
RIDE
2034
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $100K | ﹤0.01% |
1,940
-321
| -14% | -$13.9K |
|
2035
Heron Therapeutics
HRTX
$86.3M
| $99K | ﹤0.01% |
17,324
-2,822
| -14% | -$20.7K |
|
2036
MiMedx Group
MDXG
$626M
| $98K | ﹤0.01% |
20,830
-3,435
| -14% | -$16.8K |
|
|
CNSL
2037
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $98K | ﹤0.01% |
16,588
-1,996
| -11% | -$13.3K |
|
|
RUBY
2038
DELISTED
Rubius Therapeutics, Inc
RUBY
| $98K | ﹤0.01% |
17,933
-4,762
| -21% | -$30.2K |
|
2039
Hyliion Holdings
HYLN
$663M
| $97K | ﹤0.01% |
21,981
-3,629
| -14% | -$16K |
|
|
BLUE
2040
DELISTED
bluebird bio
BLUE
| $96K | ﹤0.01% |
996
-236
| -19% | -$31.1K |
|
2041
GrowGeneration
GRWG
$82.9M
| $95K | ﹤0.01% |
10,384
-1,709
| -14% | -$15.4K |
|
2042
Oil States International
OIS
$522M
| $95K | ﹤0.01% |
13,500
-1,677
| -11% | -$10.6K |
|
2043
TETRA Technologies
TTI
$1.23B
| $95K | ﹤0.01% |
23,012
-3,802
| -14% | -$12.1K |
|
|
PAYA
2044
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $95K | ﹤0.01% |
16,064
-2,653
| -14% | -$16K |
|
|
KRON
2045
DELISTED
Kronos Bio
KRON
| $94K | ﹤0.01% |
13,137
-3,282
| -20% | -$28K |
|
2046
Arbutus Biopharma
ABUS
$865M
| $93K | ﹤0.01% |
31,080
-5,519
| -15% | -$16.9K |
|
2047
Personalis
PSNL
$1.26B
| $93K | ﹤0.01% |
11,403
-2,768
| -20% | -$28.7K |
|
|
NEUE
2048
DELISTED
NeueHealth
NEUE
| $93K | ﹤0.01% |
607
+462
| +319% | +$103K |
|
2049
Advantage Solutions
ADV
$484M
| $92K | ﹤0.01% |
573
-95
| -14% | -$16.4K |
|
2050
Alto Ingredients
ALTO
$360M
| $92K | ﹤0.01% |
13,408
-2,185
| -14% | -$12.2K |
|
Similar funds
ProShare Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
- ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
- ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
- ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
- ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
- ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
- ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.
Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.